(Q30354301)

20 June 2017

1 reference

title

Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab. (English)

1 reference

progressive multifocal leukoencephalopathy

20 June 2017

0 references

author name string

Joseph R Berger

series ordinal

1

1 reference

PubMed ID

16687057

20 June 2017

Sidney Houff

series ordinal

2

1 reference

20 June 2017

1 April 2006

1 reference

20 June 2017

Neurological Research

1 reference

20 June 2017

28

1 reference

20 June 2017

3

1 reference

20 June 2017

299-305

1 reference

A controlled trial of natalizumab for relapsing multiple sclerosis.

20 June 2017

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Progressive multifocal leukoencephalopathy in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Progressive multifocal leukoencephalopathy in a patient with acquired immune deficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Epidemiology of progressive multifocal leukoencephalopathy in the United States: analysis of national mortality and AIDS surveillance data

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

PARTICLES RESEMBLING PAPOVA VIRUSES IN HUMAN CEREBRAL DEMYELINATING DISEASE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Seroepidemiology of human papovaviruses. Discovery of virgin populations and some unusual patterns of antibody prevalence among remote peoples of the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Immune response in progressive multifocal leukoencephalopathy: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Glial cells of the human developing brain and B cells of the immune system share a common DNA binding factor for recognition of the regulatory sequences of the human polyomavirus, JCV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Epidemiological evidence and molecular basis of interactions between HIV and JC virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Transcriptional activation of JC virus early promoter by phorbol ester and interleukin-1beta: critical role of nuclear factor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Natalizumab: alpha 4-integrin antagonist selective adhesion molecule inhibitors for MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Integrin-mediated long-term B cell retention in the splenic marginal zone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Detection of JC virus DNA in peripheral blood cell subpopulations of HIV-1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

α4Integrins as Therapeutic Targets in Autoimmune Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Progressive Multifocal Leukoencephalopathy in a Male Homosexual with T-Cell Immune Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Detection and typing of JC virus in autopsy brains and extraneural organs of AIDS patients and non-immunocompromised individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Semiquantitative detection of JCV-DNA in peripheral blood leukocytes from HIV-1-infected patients with or without progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Detection of JC virus DNA in the peripheral blood leukocytes of HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

Third Tysabri adverse case hits drug class

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98198

21 January 2018

Identifiers

DOI

10.1179/016164106X98198

1 reference

20 June 2017

1 reference

PubMed ID

16687057